Profile data is unavailable for this security.
About the company
Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
- Revenue in JPY (TTM)243.94bn
- Net income in JPY15.78bn
- Incorporated1957
- Employees4.59k
- LocationTowa Pharmaceutical Co Ltd2-11, Shimbashi-choKADOMA-SHI 571-8580JapanJPN
- Phone+81 669009100
- Fax+81 669082138
- Websitehttps://www.towayakuhin.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JCR Pharmaceuticals Co Ltd | 35.26bn | -437.00m | 82.74bn | 934.00 | -- | 1.41 | 26.47 | 2.35 | -3.49 | -3.49 | 281.91 | 451.84 | 0.338 | 0.4791 | 2.15 | 37,747,320.00 | -0.3864 | 8.66 | -0.5681 | 13.46 | 71.44 | 74.51 | -1.14 | 18.24 | 0.9827 | -0.3874 | 0.3325 | 30.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| Kyorin Pharmaceutical Co Ltd | 119.73bn | 4.82bn | 94.78bn | 2.04k | 17.50 | 0.6482 | 10.26 | 0.7916 | 83.83 | 83.83 | 2,084.19 | 2,263.35 | 0.6745 | 1.21 | 3.18 | 58,635,650.00 | 2.71 | 3.05 | 3.36 | 3.79 | 42.87 | 47.11 | 4.02 | 4.76 | 1.74 | -- | 0.1593 | 67.74 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
| Nxera Pharma Co Ltd | 29.28bn | -3.71bn | 100.69bn | 350.00 | -- | 1.49 | 399.57 | 3.44 | -41.70 | -41.70 | 332.11 | 753.72 | 0.194 | 2.57 | 6.61 | 83,642,860.00 | -2.46 | -0.6588 | -2.76 | -0.7036 | 75.27 | 89.83 | -12.68 | -4.46 | 3.90 | -6.02 | 0.5060 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Zeria Pharmaceutical Co Ltd | 81.47bn | 8.40bn | 117.71bn | 1.78k | 11.63 | 1.11 | 7.21 | 1.44 | 190.47 | 190.47 | 1,848.22 | 2,002.47 | 0.5316 | 1.50 | 3.60 | 45,846,530.00 | 5.49 | 3.89 | 8.46 | 6.28 | 72.99 | 71.93 | 10.33 | 7.57 | 0.9178 | -- | 0.3244 | 35.09 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| Mochida Pharmaceutical Co Ltd | 104.51bn | 4.53bn | 122.15bn | 1.52k | 25.52 | 0.8952 | 16.44 | 1.17 | 127.75 | 127.75 | 2,945.16 | 3,641.81 | 0.6639 | 1.80 | 3.42 | 68,662,940.00 | 2.88 | 4.37 | 3.41 | 5.31 | 49.61 | 52.47 | 4.34 | 6.71 | 3.50 | -- | 0.00 | 45.16 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
| Torii Pharmaceutical Co Ltd | 58.84bn | 5.28bn | 136.94bn | 583.00 | 25.33 | 1.11 | 24.04 | 2.33 | 187.71 | 187.71 | 2,093.33 | 4,271.84 | 0.4411 | 2.74 | 2.30 | 100,924,500.00 | 3.96 | 6.52 | 4.39 | 7.35 | 44.46 | 49.55 | 8.97 | 17.98 | 5.19 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Towa Pharmaceutical Co Ltd | 243.94bn | 15.78bn | 145.64bn | 4.59k | 8.82 | 0.8747 | 4.21 | 0.597 | 320.50 | 320.50 | 4,956.02 | 3,232.16 | 0.5838 | 1.52 | 3.93 | 53,169,570.00 | 3.78 | 4.21 | 4.56 | 5.63 | 36.10 | 39.23 | 6.47 | 7.23 | 1.63 | -- | 0.581 | 21.01 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
| Kissei Pharmaceutical Co Ltd | 81.07bn | 10.73bn | 182.70bn | 1.78k | 15.33 | 0.7456 | 11.96 | 2.25 | 241.71 | 241.71 | 1,825.83 | 4,969.03 | 0.3294 | 1.60 | 2.98 | 45,568,860.00 | 4.38 | 3.61 | 4.75 | 3.90 | 49.88 | 49.47 | 13.31 | 12.69 | 4.15 | -- | 0.0057 | 34.87 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
| KAKEN PHARMACEUTICAL CO., LTD. | 87.25bn | 18.24bn | 203.74bn | 1.14k | 9.21 | 1.09 | 9.75 | 2.34 | 481.71 | 481.71 | 2,303.80 | 4,076.80 | 0.4864 | 1.98 | 3.88 | 76,867,840.00 | 10.17 | 6.83 | 11.66 | 7.87 | 60.66 | 54.78 | 20.91 | 14.48 | 4.47 | -- | 0.0243 | 51.25 | -1.29 | -5.21 | 47.52 | -14.70 | 0.3639 | 0.00 |
Data as of Nov 21 2024. Currency figures normalised to Towa Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
15.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Capital Management LLCas of 30 Jun 2024 | 2.37m | 4.60% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 1.01m | 1.96% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 905.72k | 1.76% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 825.80k | 1.60% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 639.14k | 1.24% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 605.39k | 1.18% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 07 Nov 2024 | 401.20k | 0.78% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 395.80k | 0.77% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 375.20k | 0.73% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 330.30k | 0.64% |
More ▼
Data from 30 Jun 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
